BAFISONTAMAB

UNII:	G86X5QQ7M5
Formula:
Preferred Substance Name:	BAFISONTAMAB

2437210-79-0
ANTI-EGFR/ANTI-C-MET BISPECIFIC ANTIBODY EMB-01
BAFISONTAMAB [INN]
BAFISONTAMAB [USAN]
BAFISONTAMAB [WHO-DD]
EMB01
EMB-01
FIT-013A
IMMUNOGLOBULIN G1, BISPECIFIC, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET) (HUMAN .KAPPA.-CHAIN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN .GAMMA.1-CHAIN), DISULFIDE WITH IMMUNOGLOBULIN G1 ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET) HUMAN .GAMMA.1-CHAIN N-TERMINAL FRAGMENT AND IMMUNOGLOBULIN G1 ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) HUMAN .KAPPA.-CHAIN, DIMER

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BAFISONTAMAB

Synonyms and Mappings

Resources